NASDAQ:VERA | Free Cash Flow | Vera Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$106.5M$23,000.00-$106.52M
2025-12-31-$69.99M$102,000.00-$70.1M
2025-03-31-$54.41M$187,000.00-$54.59M
2024-12-31-$39.18M$645,000.00-$39.83M
2024-03-31-$33.83M$0.00-$33.83M
2023-12-31-$25.14M$63,000.00-$25.21M
2023-03-31-$26.29M$0.00-$26.29M
2022-12-31-$21.16M$0.00-$21.16M
2022-03-31-$8.98M$18,000.00-$9M
2021-12-31-$6.44M$0.00-$6.44M
2021-03-31-$4.12M$0.00-$4.12M
2020-12-31-$27.38M$0.00-$27.38M
2020-03-31-$2.31M$52,000.00-$2.36M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$241.1M$630,000.00-$241.73M
2024-12-31-$134.68M$972,000.00-$135.65M
2023-12-31-$92.18M$63,000.00-$92.24M
2022-12-31-$67.6M$62,000.00-$67.66M
2021-12-31-$23.71M$0.00-$23.71M
2020-12-31-$34.81M$99,000.00-$34.91M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.